Producing cell-based therapeutic products with lot-to-lot consistency from highly variable starting cell products

Cell & Gene Therapy Insights 2022; 8(10), 1277–1281

DOI: 10.18609/cgti.2022.185

Published: 2 November 2022
Viewpoint
William E Janssen, Scott R Burger


“Lot-to-lot consistency of therapeutic products is inextricably linked to product efficacy, safety, and generalizability of application.”